SCREENING OF CEREBROVASCULAR DISEASES IN INDIVIDUALS  AGED OVER 40 YEARS

Bustanov Oyatullox Yaqub ugli

Authors

Bustanov Oyatullox Yaqub ugli Assistant of the Department of Neurology Andijan State Medical Institute

Keywords:

cerebrovascular diseases, screening, individuals aged over 40 years, risk factors, ischemic stroke, transient ischemic attack, arterial hypertension, atherosclerosis, diabetes mellitus, dyslipidemia, prevention, early diagnosis.

Abstract

Cerebrovascular diseases (CVDs) remain one of the leading causes of mortality and disability among individuals over 40 years of age, which determines the high medical and social significance of their early detection. The aim of this article is to analyze modern approaches to screening for cerebrovascular diseases in individuals over 40 years of age and to substantiate its role in the prevention of stroke and chronic cerebral ischemia. The article discusses the main risk factors for CVDs, including arterial hypertension, atherosclerosis, diabetes mellitus, lipid metabolism disorders, and lifestyle factors. Key screening methods are described, such as clinical assessment, neuropsychological testing, Doppler ultrasound of the brachiocephalic arteries, neuroimaging, and laboratory investigations. It is shown that comprehensive screening makes it possible to detect preclinical forms of cerebrovascular pathology, to initiate timely preventive and therapeutic measures, and to reduce the risk of acute cerebrovascular events. The conclusion is drawn regarding the feasibility of implementing systematic CVD screening in primary healthcare practice among individuals over 40 years of age.

References

Chinese Stroke Association Expert Consensus on management of high-risk populations for cerebrovascular diseases, including hypertension screening and control recommendations. Stroke and Vascular Neurology. 2019;5(3):270.

Abram E. Screening and Diagnostic Tests. Medscape. Overview of screening principles and predictors for cerebrovascular and cardiovascular risk identification. Available at: Medscape eMedicine (accessed 2023).

Primary prevention of cerebrovascular disease and stroke: Recommendations on lifestyle and therapeutic interventions for asymptomatic vascular disease risk factors. Vestnik Surgery. 2025.

Risk factor profile and management data for cerebrovascular patients from the REACH Registry: prevalence, comorbid atherothrombotic disease, and undertreatment in practice. Karger Publications. 2008.

Heart and stroke risk factor review: Importance of hypertension, diabetes, dyslipidemia, obesity, atrial fibrillation, and lifestyle factors in stroke prevention. StatPearls / NCBI Bookshelf. 2025.

Dyslipidemias and stroke prevention: Recommendations on vascular risk stratification and management in dyslipidemia patients. Dyslipidemias and Stroke Prevention, Spanish Society of Neurology. 2022.

Cardiometabolic risk assessment and management standards in patients with dysglycemia, emphasizing integrated vascular risk evaluation. Karger Cardiometabolic Guidelines. 2025.

Methodological aspects of cerebrovascular disease screening in general medical practice, including practical tools and questionnaires. Russian Journal of Preventive Medicine. 2017.

Epidemiological study on cerebrovascular risk factors in adults aged 40–59, including arterial hypertension and atherosclerosis prevalence trends. CyberLeninka Health Sciences Publications. 2025.

National guidelines on ischemic stroke and TIA secondary prevention, including blood pressure control and lifestyle modifications. Clinical Recommendations, 2024